Stonehage Fleming (UK)’s Repligen RGEN Stock Holding History

Stonehage Fleming (UK)’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-1,397	Closed	-$28K	–	249
2014 Q4	$28K	Buy	+1,397	New	+$31.2K	0.01%	228

Other funds holding RGEN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Stonehage Fleming (UK)'s RGEN Position: Q1 2015 in Review

Stonehage Fleming (UK) sold out of Repligen (RGEN) in Q1 2015, closing a stake of 1,397 shares — an estimated $28K sold.

Stonehage Fleming (UK) first reported a position in RGEN in Q4 2014 and held it in 1 quarter. The position peaked at $28K in Q4 2014. 168 funds tracked by Wall St. Rank hold RGEN as of Q1 2015.

Stonehage Fleming (UK) reported no remaining Repligen position as of Q1 2015 after selling out during the quarter.
Stonehage Fleming (UK) sold 1,397 Repligen shares in Q1 2015, an estimated $28K.
Stonehage Fleming (UK) first reported a position in Repligen in Q4 2014 and held it in 1 quarter.
Stonehage Fleming (UK)'s Repligen position peaked at $28K in Q4 2014.
168 funds tracked by Wall St. Rank held Repligen as of Q1 2015.

Based on Stonehage Fleming (UK)'s 13F filing for Q1 2015, filed 11 Oct 2019.